It is also important that CKLF1-induced glycolysis was dependent on the regulation of AMPK/mTOR signaling pathway, and both mTOR and AMPK were once considered as potential therapeutic targets for the treatment of stroke. This evidence concerns the gene PRKAA2 and Stroke.